Fieldfisher has advised Ultromics on the deal. The $33 million Series B funding round was led by the Blue Venture Fund with participation from Optum Ventures,...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here